Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Bladder Cancer, January 2016

Free Subscription


Abstracts

Retrieve all available abstracts of the following 363 articles:
HTML format


 

Single Articles

  1. WANG YY, Wu ZY, Wang GC, Liu K, et al
    LINC00312 inhibits the migration and invasion of bladder cancer cells by targeting miR-197-3p.
    Tumour Biol. 2016.
    Abstract     Related articles   

  2. YU Y, Li X, Liang C, Tang J, et al
    The relationship between GSTA1, GSTM1, GSTP1, and GSTT1 genetic polymorphisms and bladder cancer susceptibility: A meta-analysis.
    Medicine (Baltimore). 2016;95:e4900.
    Abstract     Related articles   

  3. CHEN Z, Wu L, Lin Q, Shi J, et al
    Evaluation of miR-182/miR-100 Ratio for Diagnosis and Survival Prediction in Bladder Cancer.
    Arch Iran Med. 2016;19:645-51.
    Abstract     Related articles   

  4. KEEHN A, Ludmir E, Taylor J, Rabbani F, et al
    Incidence of bladder cancer after radiation for prostate cancer as a function of time and radiation modality.
    World J Urol. 2016.
    Abstract     Related articles   

  5. SHI J, Fu S, Wang L, Tao Y, et al
    Lentivirus-mediated p21/Waf-1 short hairpin RNA enhances the cytotoxic effects and replicative potential of a bladder cancer-specific oncolytic adenovirus in vitro.
    Anticancer Drugs. 2016.
    Abstract     Related articles   

  6. KEY J, Dhawan D, Cooper CL, Knapp DW, et al
    Multicomponent, peptide-targeted glycol chitosan nanoparticles containing ferrimagnetic iron oxide nanocubes for bladder cancer multimodal imaging.
    Int J Nanomedicine. 2016;11:4141-55.
    Abstract     Related articles   

  7. STONE L
    Bladder cancer: Two molecular subtypes identified.
    Nat Rev Urol. 2016 Sep 13. doi: 10.1038/nrurol.2016.
    Abstract     Related articles   

  8. GUAL FRAU J, Palou J, Rodriguez O, Parada R, et al
    Failure of Bacillus Calmette-Guerin therapy in non-muscle-invasive bladder cancer: Definition and treatment options.
    Arch Esp Urol. 2016;69:423-33.
    Abstract     Related articles   

  9. KANG M, Ku JH
    Liquid biopsy? A recent breakthrough in noninvasive bladder cancer surveillance.
    Investig Clin Urol. 2016;57:307-8.
    Abstract     Related articles   

  10. IEDA T, Muto S, Shimizu F, Taguri M, et al
    Development and Validation of a Novel Recurrence Risk Stratification for Initial Non-muscle Invasive Bladder Cancer in Asia.
    EBioMedicine. 2016 Sep 2. pii: S2352-3964(16)30405.
    Abstract     Related articles   

  11. GAISA NT
    [Tumorigenesis from a pathological perspective : Tumor spread and epigenetically regulated genes in bladder cancer].
    Pathologe. 2016.
    Abstract     Related articles   

  12. DADHANIA V, Zhang M, Zhang L, Bondaruk J, et al
    Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use.
    EBioMedicine. 2016 Aug 25. pii: S2352-3964(16)30391.
    Abstract     Related articles   

  13. KLAUTKE G
    [Radical cystectomy vs. chemoradiation for the treatment of T2-4a N0 M0 bladder cancer].
    Strahlenther Onkol. 2016.
    Abstract     Related articles   

  14. ZHOU J, Dong D, Cheng R, Wang Y, et al
    Aberrant expression of KPNA2 is associated with a poor prognosis and contributes to OCT4 nuclear transportation in bladder cancer.
    Oncotarget. 2016 Sep 7. doi: 10.18632/oncotarget.11889.
    Abstract     Related articles   

  15. CRITELLI R, Fasanelli F, Oderda M, Polidoro S, et al
    Detection of multiple mutations in urinary exfoliated cells from male bladder cancer patients at diagnosis and during follow-up.
    Oncotarget. 2016 Sep 7. doi: 10.18632/oncotarget.11883.
    Abstract     Related articles   

  16. KEEHN A, Gartrell B, Schoenberg MP
    Vesigenurtacel-L (HS-410) in the management of high-grade nonmuscle invasive bladder cancer.
    Future Oncol. 2016.
    Abstract     Related articles   

  17. WANG L, Zhou Z, Gong MZ, Pan DL, et al
    A Large Bladder Tumor Covered With a Thick "Shell" of Necrotic Material: Misdiagnosis of a Patient With Spina Bifida.
    Medicine (Baltimore). 2016;95:e3443.
    Abstract     Related articles   

  18. LUO Y, Zhang X, Mo M, Tan Z, et al
    High Ki-67 Immunohistochemical Reactivity Correlates With Poor Prognosis in Bladder Carcinoma: A Comprehensive Meta-Analysis with 13,053 Patients Involved.
    Medicine (Baltimore). 2016;95:e3337.
    Abstract     Related articles   

  19. SAINT-JACQUES N, Lee JS, Brown P, Stafford J, et al
    Small-area spatio-temporal analyses of bladder and kidney cancer risk in Nova Scotia, Canada.
    BMC Public Health. 2016;16:175.
    Abstract     Related articles   

  20. ZHENG CL, Han XH, Feng SN, Wang JZ, et al
    [Value of urine sediment analyzer in the screening of urinary tract infection in cancer patients].
    Zhonghua Zhong Liu Za Zhi. 2016;38:35-9.
    Abstract     Related articles   

  21. ARTHUR EG, Arthur GL, Keeler MR, Bryan JN, et al
    Risk of Osteosarcoma in Dogs After Open Fracture Fixation.
    Vet Surg. 2016;45:30-5.
    Abstract     Related articles   

  22. AGARWAL KK, Roy SG, Kumar R
    Diuretic 18F-Fluorodeoxyglucose PET/Computed Tomography in Evaluation of Genitourinary Malignancies.
    PET Clin. 2016;11:39-46.
    Abstract     Related articles   

  23. SHIMADA K, Fujii T, Tatsumi Y, Anai S, et al
    Ubiquilin2 as a novel marker for detection of urothelial carcinoma cells in urine.
    Diagn Cytopathol. 2016;44:3-9.
    Abstract     Related articles   

  24. XIAO D, Zhang G, Liu Y, Yang Z, et al
    3D detection and extraction of bladder tumors via MR virtual cystoscopy.
    Int J Comput Assist Radiol Surg. 2016;11:89-97.
    Abstract     Related articles   

  25. BROOKS M, Mo Q, Krasnow R, Ho PL, et al
    Positive association of collagen type I with non-muscle invasive bladder cancer progression.
    Oncotarget. 2016 Sep 17. doi: 10.18632/oncotarget.12089.
    Abstract     Related articles   

  26. HAN MH, Lee DS, Jeong JW, Hong SH, et al
    Fucoidan Induces ROS-Dependent Apoptosis in 5637 Human Bladder Cancer Cells by Downregulating Telomerase Activity via Inactivation of the PI3K/Akt Signaling Pathway.
    Drug Dev Res. 2016 Sep 21. doi: 10.1002/ddr.21367.
    Abstract     Related articles   

  27. ROSHDY S, Senbel A, Khater A, Farouk O, et al
    Genital Sparing Cystectomy for Female Bladder Cancer and its Functional Outcome; a Seven Years' Experience with 24 Cases.
    Indian J Surg Oncol. 2016;7:307-11.
    Abstract     Related articles   

  28. KUPPACHI S, Holanda D, Eberlein M, Alexiev B, et al
    An unexpected surge in plasma BKPyV viral load heralds the development of BKPyV associated metastatic bladder cancer in a lung transplant recipient with BKPyV nephropathy.
    Am J Transplant. 2016 Sep 20. doi: 10.1111/ajt.14057.
    Abstract     Related articles   

  29. MBEUTCHA A, Shariat SF, Rieken M, Rink M, et al
    Prognostic significance of markers of systemic inflammatory response in patients with non-muscle-invasive bladder cancer.
    Urol Oncol. 2016 Sep 16. pii: S1078-1439(16)30065.
    Abstract     Related articles   

  30. ANDERSON-OTUNU O, Akhtar S
    Chronic Infections of the Urinary Tract and Bladder Cancer Risk: a Systematic Review.
    Asian Pac J Cancer Prev. 2016;17:3805-7.
    Abstract     Related articles   

  31. SOLAKHAN M, Demirpence O, Orhan N, Yildirim OA, et al
    Lack of Any Role of Systemic Inflammatory Responses in Predicting Muscle Invasion by Bladder Cancer.
    Asian Pac J Cancer Prev. 2016;17:3737-9.
    Abstract     Related articles   

  32. DONG BB, Yan JS, Yan YY, Xie TC, et al
    Downregulation of Pigment epithelium-derived factor is associated with increased epithelial-mesenchymal transition (EMT) in bladder cancer.
    Panminerva Med. 2016.
    Abstract     Related articles   

  33. PAN A, Zhang H, Li Y, Lin TY, et al
    Disulfide-crosslinked nanomicelles confer cancer-specific drug delivery and improve efficacy of paclitaxel in bladder cancer.
    Nanotechnology. 2016;27:425103.
    Abstract     Related articles   

  34. BRANT A, Kates M, Chappidi MR, Patel HD, et al
    Pathologic response in patients receiving neoadjuvant chemotherapy for muscle-invasive bladder cancer: Is therapeutic effect owing to chemotherapy or TURBT?
    Urol Oncol. 2016 Sep 14. pii: S1078-1439(16)30214.
    Abstract     Related articles   

  35. WITJES JA, Dalbagni G, Karnes RJ, Shariat S, et al
    The efficacy of BCG TICE and BCG Connaught in a cohort of 2,099 patients with T1G3 non-muscle-invasive bladder cancer.
    Urol Oncol. 2016 Sep 14. pii: S1078-1439(16)30114.
    Abstract     Related articles   

  36. PECHERY A, Fauconnet S, Bittard H, Lascombe I, et al
    Apoptotic effect of the selective PPARbeta/delta agonist GW501516 in invasive bladder cancer cells.
    Tumour Biol. 2016.
    Abstract     Related articles   

  37. KOPSIAFTIS S, Sullivan KL, Garg I, Taylor JA, et al
    AMPKalpha2 Regulates Bladder Cancer Growth Through SKP2-mediated Degradation of p27.
    Mol Cancer Res. 2016 Sep 16. pii: molcanres.0111.2016.
    Abstract     Related articles   

  38. PASSONI N, Gayed B, Kapur P, Sagalowsky AI, et al
    Cell-cycle markers do not improve discrimination of EORTC and CUETO risk models in predicting recurrence and progression of non-muscle-invasive high-grade bladder cancer.
    Urol Oncol. 2016 Sep 13. pii: S1078-1439(16)30066.
    Abstract     Related articles   

  39. LEBENTRAU S, May M, Weckermann D, Speck T, et al
    [Non-muscle-invasive bladder cancer: Information transfer from the clinic to the doctor's office : Results of a questionnaire study and presentation of a software solution].
    Urologe A. 2016.
    Abstract     Related articles   

  40. REXER H, Merseburger A
    [Neoadjuvant therapy before radical cystectomy for muscle-invasive bladder cancer].
    Urologe A. 2016.
    Abstract     Related articles   

  41. WU TF, Hsu LT, Tsang BX, Huang LC, et al
    Clarification of the molecular pathway of Taiwan local pomegranate fruit juice underlying the inhibition of urinary bladder urothelial carcinoma cell by proteomics strategy.
    BMC Complement Altern Med. 2016;16:96.
    Abstract     Related articles   

  42. RAGGI D, Miceli R, Sonpavde G, Giannatempo P, et al
    Second-line single-agent versus doublet chemotherapy as salvage therapy for metastatic urothelial cancer: a systematic review and meta-analysis.
    Ann Oncol. 2016;27:49-61.
    Abstract     Related articles   

  43. MIYAKE M, Hori S, Morizawa Y, Tatsumi Y, et al
    CXCL1-Mediated Interaction of Cancer Cells with Tumor-Associated Macrophages and Cancer-Associated Fibroblasts Promotes Tumor Progression in Human Bladder Cancer.
    Neoplasia. 2016;18:636-646.
    Abstract     Related articles   

  44. ZHAO J, Xu W, He M, Zhang Z, et al
    Whole-exome sequencing of muscle-invasive bladder cancer identifies recurrent copy number variation in IPO11 and prognostic significance of importin-11 overexpression on poor survival.
    Oncotarget. 2016 Sep 28. doi: 10.18632/oncotarget.12315.
    Abstract     Related articles   

  45. KAELBERER JB, O'Donnell MA, Mitchell DL, Snow AN, et al
    Incidental prostate cancer diagnosed at radical cystoprostatectomy for bladder cancer: disease-specific outcomes and survival.
    Prostate Int. 2016;4:107-12.
    Abstract     Related articles   

  46. POLETAJEW S, Biernacki R, Buraczynski P, Chojnacki J, et al
    Patterns of care in patients with muscle-invasive bladder cancer - a retrospective cohort study.
    Contemp Oncol (Pozn). 2016;20:341-3.
    Abstract     Related articles   

  47. WANG G, Zhao MJ, Liu YQ, Liu XW, et al
    Fiber-modified adenovirus-mediated suicide gene therapy can efficiently eliminate bladder cancer cells in vitro and in vivo.
    Oncotarget. 2016 Sep 28. doi: 10.18632/oncotarget.12324.
    Abstract     Related articles   

  48. HUANG J, Chen X, Lin TX
    [Strategies for diagnosis and treatment of bladder cancer in precise times].
    Zhonghua Wai Ke Za Zhi. 2016;54:734-737.
    Abstract     Related articles   

  49. FRANTZI M, Klimou Z, Makridakis M, Zoidakis J, et al
    Silencing of Profilin-1 suppresses cell adhesion and tumor growth via predicted alterations in integrin and Ca2+ signaling in T24M-based bladder cancer models.
    Oncotarget. 2016 Sep 23. doi: 10.18632/oncotarget.12218.
    Abstract     Related articles   

  50. GIL D, Ciolczyk-Wierzbicka D, Dulinska-Litewka J, Laidler P, et al
    Integrin-linked kinase regulates cadherin switch in bladder cancer.
    Tumour Biol. 2016.
    Abstract     Related articles   

  51. JOSEPH N, Choudhury A
    Adjuvant Chemotherapy Is More Suitable Than Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer Patients Treated With Radical Chemoradiotherapy.
    Int J Radiat Oncol Biol Phys. 2016;96:614-6.
    Abstract     Related articles   

  52. VALLO S, Michaelis M, Gust KM, Black PC, et al
    Dasatinib enhances tumor growth in gemcitabine-resistant orthotopic bladder cancer xenografts.
    BMC Res Notes. 2016;9:454.
    Abstract     Related articles   

  53. SANCHEZ A, Wszolek MF, Drumm MR, Niemierko A, et al
    The Natural History of Nonmuscle-Invasive Bladder Cancer Recurrences After Complete Response to Combined-Modality Organ-Preserving Therapy for Muscle-Invasive Bladder Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    Abstract     Related articles   

  54. OJERHOLM EJ, Smith A, Hwang WT, Baumann BC, et al
    Neutrophil-to-Lymphocyte Ratio as a Bladder Cancer Biomarker: Assessing Prognostic and Predictive Value in SWOG 8710.
    Int J Radiat Oncol Biol Phys. 2016;96.
    Abstract     Related articles   

  55. ROBERTS HJ, Krasnow RE, Drumm MR, Niemierko A, et al
    Clinical Outcomes of Combined Modality Bladder-Sparing Therapy for Patients With Histologic Variants of Bladder Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    Abstract     Related articles   

  56. ZAGHLOUL MS, Christodouleas JP, Smith A, Abdalla A, et al
    Adjuvant Sandwich Chemotherapy and Radiation Versus Adjuvant Chemotherapy Alone for Locally Advanced Bladder Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    Abstract     Related articles   

  57. BLOCK AM, Harkenrider MM, Henry E, Gaynor ER, et al
    Concurrent Chemotherapy Improves Overall Survival in Muscle-Invasive Bladder Cancer Patients Undergoing Radiation Therapy: An Analysis of the National Cancer Data Base.
    Int J Radiat Oncol Biol Phys. 2016;96.
    Abstract     Related articles   

  58. ZHONG J, Switchenko J, Jegadeesh N, Gillespie TW, et al
    Comparison of Outcomes in Patients With Muscle-Invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder-Preserving Chemoradiation.
    Int J Radiat Oncol Biol Phys. 2016;96.
    Abstract     Related articles   

  59. MOUW K, Braunstein LZ, Kim J, Polak P, et al
    Somatic ERCC2 Mutations Are Associated With a Distinct Mutational Signature in Muscle-Invasive Bladder Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    Abstract     Related articles   

  60. WILLERS H, Liu Q, Efstathiou JA, Gheorghiu L, et al
    PARP1 Inhibition Radiosensitizes A Subset Of Genotype-Defined Bladder Cancers Through Modulation Of Reactive Oxygen Species.
    Int J Radiat Oncol Biol Phys. 2016;96.
    Abstract     Related articles   

  61. KORPICS M, Block AM, Harkenrider MM, Welsh JS, et al
    The Impact of Radiation Therapy Dose on Survival in Patients with Muscle-Invasive Bladder Cancer: A Population-Based Analysis.
    Int J Radiat Oncol Biol Phys. 2016;96.
    Abstract     Related articles   

  62. TUANQUIN LC, McDermott D, Mackley HB, Holder S, et al
    The Outcomes of Adjuvant Radiation Therapy in Postcystectomy Muscle-Invasive Bladder Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    Abstract     Related articles   

  63. SOLANKI AA, Korpics M, Small C, Harkenrider MM, et al
    Variability of Radiation Oncologists' Chemoradiation Therapy Patterns of Care and the Impact of Multidisciplinary Clinics in Muscle-Invasive Bladder Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    Abstract     Related articles   

  64. FISCHER-VALUCK BW, Green OL, Mutic S, Gay HA, et al
    Vector Analysis of Bladder Cancer Patient Setup Utilizing a Magnetic Resonance Image Guided Radiation Therapy (MR-IGRT) System.
    Int J Radiat Oncol Biol Phys. 2016;96.
    Abstract     Related articles   

  65. FILONENKO EV, Kaprin AD, Alekseev BY, Apolikhin OI, et al
    5-Aminolevulinic acid in intraoperative photodynamic therapy of bladder cancer (results of multicenter trial).
    Photodiagnosis Photodyn Ther. 2016 Sep 23. pii: S1572-1000(16)30054.
    Abstract     Related articles   

  66. STONE L
    Bladder cancer: Rho-sensitive pathway mediates metastasis.
    Nat Rev Urol. 2016 Sep 27. doi: 10.1038/nrurol.2016.
    Abstract     Related articles   

  67. BALDIA PH, Maurer A, Heide T, Rose M, et al
    Fibroblast growth factor receptor (FGFR) alterations in squamous differentiated bladder cancer: a putative therapeutic target for a small subgroup.
    Oncotarget. 2016 Sep 22. doi: 10.18632/oncotarget.12198.
    Abstract     Related articles   

  68. SORIA F, Moschini M, Haitel A, Wirth GJ, et al
    The effect of HER2 status on oncological outcomes of patients with invasive bladder cancer.
    Urol Oncol. 2016 Sep 21. pii: S1078-1439(16)30169.
    Abstract     Related articles   

  69. XIA L, Guzzo TJ
    Preoperative Anemia and Low Hemoglobin Level Are Associated With Worse Clinical Outcomes in Patients With Bladder Cancer Undergoing Radical Cystectomy: A Meta-Analysis.
    Clin Genitourin Cancer. 2016 Aug 29. pii: S1558-7673(16)30251.
    Abstract     Related articles   

  70. CAO R, Meng Z, Liu T, Wang G, et al
    Decreased TRPM7 inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway.
    Oncotarget. 2016 Sep 20. doi: 10.18632/oncotarget.12146.
    Abstract     Related articles   

  71. JIN X, Zhang P, Luo L, Cheng H, et al
    Efficient intravesical therapy of bladder cancer with cationic doxorubicin nanoassemblies.
    Int J Nanomedicine. 2016;11:4535-4544.
    Abstract     Related articles   

  72. CHEN DJ, Chen W, Jiang H, Yang H, et al
    Downregulation of DOCK1 sensitizes bladder cancer cells to cisplatin through preventing epithelial-mesenchymal transition.
    Drug Des Devel Ther. 2016;10:2845-2853.
    Abstract     Related articles   

  73. DE PAOLI M, Gogalic S, Sauer U, Preininger C, et al
    Multiplatform Biomarker Discovery for Bladder Cancer Recurrence Diagnosis.
    Dis Markers. 2016;2016:4591910.
    Abstract     Related articles   

  74. OGIHARA K, Kikuchi E, Yuge K, Yanai Y, et al
    The Preoperative Neutrophil-to-lymphocyte Ratio is a Novel Biomarker for Predicting Worse Clinical Outcomes in Non-muscle Invasive Bladder Cancer Patients with a Previous History of Smoking.
    Ann Surg Oncol. 2016.
    Abstract     Related articles   

  75. VLAHOU A, Black PC, Goebell PJ, Kamat AM, et al
    Taking the next step-Advancing bladder cancer management.
    Urol Oncol. 2016;34:435-6.
    Abstract     Related articles   

  76. JENSEN TK, Jensen NV, Jorgensen SM, Clark P, et al
    Trends in cancer of the urinary bladder and urinary tract in elderly in Denmark, 2008-2012.
    Acta Oncol. 2016;55 Suppl 1:85-90.
    Abstract     Related articles   

  77. YADAV S, Banerjee I, Tomar V, Yadav SS, et al
    Pelvic paraganglioma: a rare and unusual clinical presentation of paraganglioma.
    BMJ Case Rep. 2016;2016.
    Abstract     Related articles   

  78. CHUNG KT
    Carcinogenicity, allergenicity, and lupus-inducibility of arylamines.
    Front Biosci (Elite Ed). 2016;8:29-39.
    Abstract     Related articles   

  79. CAO Q, Wang N, Qi J, Gu Z, et al
    Long noncoding RNAGAS5 acts as a tumor suppressor in bladder transitional cell carcinoma via regulation of chemokine (CC motif) ligand 1 expression.
    Mol Med Rep. 2016;13:27-34.
    Abstract     Related articles   

  80. HUANG YC, Yu HS, Chai CY
    Aldehyde dehydrogenase induction in arsenic-exposed rat bladder epithelium.
    Exp Toxicol Pathol. 2016;68:61-8.
    Abstract     Related articles   

  81. GERSHMAN B, Moreira DM, Tollefson MK, Frank I, et al
    The association of ABO blood type with disease recurrence and mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy.
    Urol Oncol. 2016;34:4.
    Abstract     Related articles   

  82. HAYASHI T, Yuasa T, Uehara S, Inoue Y, et al
    Clinical outcome of urachal cancer in Japanese patients.
    Int J Clin Oncol. 2016;21:133-8.
    Abstract     Related articles   

  83. LIU Y, Yang W, Zhao L, Liang Z, et al
    Immune analysis of expression of IL-17 relative ligands and their receptors in bladder cancer: comparison with polyp and cystitis.
    BMC Immunol. 2016;17:36.
    Abstract     Related articles   

  84. PALMER S, Litvinova K, Dunaev A, Yubo J, et al
    Optical redox ratio and endogenous porphyrins in the detection of urinary bladder cancer: A patient biopsy analysis.
    J Biophotonics. 2016 Oct 7. doi: 10.1002/jbio.201600162.
    Abstract     Related articles   

  85. PRASAIN JK, Rajbhandari R, Keeton AB, Piazza GA, et al
    Metabolism and growth inhibitory activity of cranberry derived flavonoids in bladder cancer cells.
    Food Funct. 2016;7:4012-4019.
    Abstract     Related articles   

  86. YANG Y, Deng S, Zeng Q, Hu W, et al
    Highly stable selenadiazole derivatives induce bladder cancer cell apoptosis and inhibit cell migration and invasion through the activation of ROS-mediated signaling pathways.
    Dalton Trans. 2016.
    Abstract     Related articles   

  87. LI XZ, Han Y, Tian J, Ren X, et al
    Enhancement of dendritic cells with melanoma-associated antigen 3 for inducing cytotoxicity by cytotoxic T lymphocytes on bladder cancer BIU-87 cells.
    Genet Mol Res. 2016;15.
    Abstract     Related articles   

  88. CHOI BH, Lee DH, Kim J, Kang JH, et al
    Controls of Nuclear Factor-Kappa B Signaling Activity by 5'-AMP-Activated Protein Kinase Activation With Examples in Human Bladder Cancer Cells.
    Int Neurourol J. 2016;20:182-187.
    Abstract     Related articles   

  89. HIRASAWA Y, Nakashima J, Yunaiyama D, Sugihara T, et al
    Sarcopenia as a Novel Preoperative Prognostic Predictor for Survival in Patients with Bladder Cancer Undergoing Radical Cystectomy.
    Ann Surg Oncol. 2016.
    Abstract     Related articles   

  90. ZHOU J, Duan H, Xie Y, Ning Y, et al
    MiR-193a-5p Targets the Coding Region of AP-2alpha mRNA and Induces Cisplatin Resistance in Bladder Cancers.
    J Cancer. 2016;7:1740-1746.
    Abstract     Related articles   

  91. MATSUMOTO R, Tsuda M, Yoshida K, Tanino M, et al
    Aldo-keto reductase 1C1 induced by interleukin-1beta mediates the invasive potential and drug resistance of metastatic bladder cancer cells.
    Sci Rep. 2016;6:34625.
    Abstract     Related articles   

  92. CLARK PE, Spiess PE, Agarwal N, Bangs R, et al
    NCCN Guidelines Insights: Bladder Cancer, Version 2.2016.
    J Natl Compr Canc Netw. 2016;14:1213-1224.
    Abstract     Related articles   

  93. JANG D, Lim CS, Shin YS, Ko YK, et al
    A comparison of regional and general anesthesia effects on 5 year survival and cancer recurrence after transurethral resection of the bladder tumor: a retrospective analysis.
    BMC Anesthesiol. 2016;16:16.
    Abstract     Related articles   

  94. FALTAS B, Goldenberg DM, Ocean AJ, Govindan SV, et al
    Sacituzumab Govitecan, a Novel Antibody--Drug Conjugate, in Patients With Metastatic Platinum-Resistant Urothelial Carcinoma.
    Clin Genitourin Cancer. 2016;14:e75-9.
    Abstract     Related articles   

  95. ADEJORO O, Alishahi A, Soubra A, Konety B, et al
    Trends in PET Scan Usage for Imaging of Patients Diagnosed With Nonmetastatic Urologic Cancer.
    Clin Genitourin Cancer. 2016;14:38-47.
    Abstract     Related articles   

  96. PALAZZETTI A, Oderda M, Falcone M, Cassenti A, et al
    Osteoclast-Like Giant Cell Carcinoma Hidden by a Bladder Stone in a Patient With Neurogenic Bladder.
    Clin Genitourin Cancer. 2016;14:e127-30.
    Abstract     Related articles   

  97. POKURI VK, Syed JR, Yang Z, Field EP, et al
    Predictors of Complete Pathologic Response (pT0) to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Carcinoma.
    Clin Genitourin Cancer. 2016;14:e59-65.
    Abstract     Related articles   

  98. WYMER KM, Antic T, O'Donnell PH
    Case Report of a Rare Presentation of Urothelial Carcinoma With Gastric Metastasis.
    Clin Genitourin Cancer. 2016;14:e111-4.
    Abstract     Related articles   

  99. KIM YS, Lee SI, Park SH, Park S, et al
    A Phase II Study of Weekly Docetaxel as Second-Line Chemotherapy in Patients With Metastatic Urothelial Carcinoma.
    Clin Genitourin Cancer. 2016;14:76-81.
    Abstract     Related articles   

  100. WINTERS BR, Bremjit PJ, Gore JL, Lin DW, et al
    Preliminary Comparative Effectiveness of Robotic Versus Open Radical Cystectomy in Elderly Patients.
    J Endourol. 2016;30:212-7.
    Abstract     Related articles   

  101. ZARGAR-SHOSHTARI K, Sverrisson EF, Sharma P, Gupta S, et al
    Clinical Outcomes After Neoadjuvant Chemotherapy and Radical Cystectomy in the Presence of Urothelial Carcinoma of the Bladder With Squamous or Glandular Differentiation.
    Clin Genitourin Cancer. 2016;14:82-8.
    Abstract     Related articles   

  102. PINCIROLI P, Won H, Iyer G, Canevari S, et al
    Molecular Signature of Response to Pazopanib Salvage Therapy for Urothelial Carcinoma.
    Clin Genitourin Cancer. 2016;14:e81-90.
    Abstract     Related articles   

  103. WANG J, Chen X, Liu Y, Chen J, et al
    Cystic Angiomyolipomas in the Bladder: A Case Report With Imaging Findings and Review of the Literature.
    Clin Genitourin Cancer. 2016;14:e99-e102.
    Abstract     Related articles   

  104. KANG M, Jeong CW, Kwak C, Kim HH, et al
    The Prognostic Significance of the Early Postoperative Neutrophil-to-Lymphocyte Ratio in Patients with Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy.
    Ann Surg Oncol. 2016;23:335-42.
    Abstract     Related articles   

  105. UCER O, Albaz AC, Atag E, Karaoglu A, et al
    The Rate of Neoadjuvant Chemotherapy Use in Muscle Invasive Bladder Cancer and The Approach of Urologists in Turkey.
    Urol J. 2016;13:2841-2844.
    Abstract     Related articles   

  106. YOSHIDA T, Kinoshita H, Fukui K, Matsuzaki T, et al
    Prognostic Impact of Renin-Angiotensin Inhibitors in Patients with Bladder Cancer Undergoing Radical Cystectomy.
    Ann Surg Oncol. 2016.
    Abstract     Related articles   

  107. MAK KS, Smith AB, Eidelman A, Clayman R, et al
    Quality of Life in Long-term Survivors of Muscle-Invasive Bladder Cancer.
    Int J Radiat Oncol Biol Phys. 2016 Aug 24. pii: S0360-3016(16)33135.
    Abstract     Related articles   

  108. KUMONDAI M, Hosono H, Orikasa K, Arai Y, et al
    CYP2A13 Genetic Polymorphisms in Relation to the Risk of Bladder Cancer in Japanese Smokers.
    Biol Pharm Bull. 2016;39:1683-1686.
    Abstract     Related articles   

  109. RESHETNIKOVA G, Sidorenko VS, Whyard T, Lukin M, et al
    Genotoxic and cytotoxic effects of the environmental pollutant 3-nitrobenzanthrone on bladder cancer cells.
    Exp Cell Res. 2016 Oct 5. pii: S0014-4827(16)30318.
    Abstract     Related articles   

  110. LAURENT M, Brureau L, Demery ME, Flechon A, et al
    Early chemotherapy discontinuation and mortality in older patients with metastatic bladder cancer: The AGEVIM multicenter cohort study.
    Urol Oncol. 2016 Oct 6. pii: S1078-1439(16)30211.
    Abstract     Related articles   

  111. MOSCHINI M, Luzzago S, Zaffuto E, Dell'Oglio P, et al
    The surgical management of patients with clinical stage T4 bladder cancer: A single institution experience.
    Eur J Surg Oncol. 2016 Sep 28. pii: S0748-7983(16)30897.
    Abstract     Related articles   

  112. CAFFO O, Thompson C, De Santis M, Kragelj B, et al
    Concurrent gemcitabine and radiotherapy for the treatment of muscle-invasive bladder cancer: A pooled individual data analysis of eight phase I-II trials.
    Radiother Oncol. 2016 Oct 5. pii: S0167-8140(16)34304.
    Abstract     Related articles   

  113. ZHUO Y, Chen Q, Chen B, Zhan X, et al
    Berberine promotes antiproliferative effects of epirubicin in T24 bladder cancer cells by enhancing apoptosis and cell cycle arrest.
    Int J Clin Pharmacol Ther. 2016.
    Abstract     Related articles   

  114. ORYWAL K, Jelski W, Werel T, Szmitkowski M, et al
    The activity of class I, II, III and IV alcohol dehydrogenase isoenzymes and aldehyde dehydrogenase in the sera of bladder cancer patients.
    Acta Biochim Pol. 2016.
    Abstract     Related articles   

  115. GOODISON S, Ogawa O, Matsui Y, Kobayashi T, et al
    A multiplex urinary immunoassay for bladder cancer detection: analysis of a Japanese cohort.
    J Transl Med. 2016;14:287.
    Abstract     Related articles   

  116. WAKABAYASHI Y, Iwaya M, Akita M, Takeuchi W, et al
    Pulmonary Tumor Thrombotic Microangiopathy Caused by Urothelial Carcinoma Expressing Vascular Endothelial Growth Factor, Platelet-derived Growth Factor, and Osteopontin.
    Intern Med. 2016;55:651-6.
    Abstract     Related articles   

  117. OHTAKA M, Kawahara T, Kumano Y, Maeda Y, et al
    Invasive urothelial carcinoma, lymphoma-like/plasmacytoid variant, successfully treated by radical cystectomy with adjuvant chemotherapy: a case report.
    J Med Case Rep. 2016;10:48.
    Abstract     Related articles   

  118. NAWAR NA, Olsen J, Jelic TM, He C, et al
    Primary Urinary Bladder Angiosarcoma with Osteoclast-Like Multinucleated Giant Cells: A Case Report and Literature Review.
    Am J Case Rep. 2016;17:143-9.
    Abstract     Related articles   

  119. PATRIARCA C, Hurle R, Moschini M, Freschi M, et al
    Usefulness of pT1 substaging in papillary urothelial bladder carcinoma.
    Diagn Pathol. 2016;11:6.
    Abstract     Related articles   

  120. FUKUMOTO K, Kikuchi E, Mikami S, Miyajima A, et al
    Lymphovascular invasion status at transurethral resection of bladder tumors may predict subsequent poor response of T1 tumors to bacillus Calmette-Guerin.
    BMC Urol. 2016;16:5.
    Abstract     Related articles   

  121. CHEN Y, Hong C, Ning Y, Su X, et al
    Meta-analysis of studies with bivariate binary outcomes: a marginal beta-binomial model approach.
    Stat Med. 2016;35:21-40.
    Abstract     Related articles   

  122. WANG QH, Ji ZG, Li HZ, Fan H, et al
    Clinicopathologic Comparison of Urothelial Bladder Carcinoma in Young and Elder Patients.
    Pathol Oncol Res. 2016;22:67-70.
    Abstract     Related articles   

  123. WANG F, Wu D, He F, Fu H, et al
    Study on the significance of Cofilin 1 overexpression in human bladder cancer.
    Tumori. 2016 Oct 21:0. doi: 10.5301/tj.5000569.
    Abstract     Related articles   

  124. COLOMBO R, van Valenberg H, Moschini M, Witjes JA, et al
    Radiofrequency-induced thermo-chemotherapy effect (RITE) for non muscle invasive bladder cancer treatment: current role and perspectives.
    Urologia. 2016;83.
    Abstract     Related articles   

  125. LIN F, Dong L, Wang W, Liu Y, et al
    An Efficient Light-Inducible P53 Expression System for Inhibiting Proliferation of Bladder Cancer Cell.
    Int J Biol Sci. 2016;12:1273-1278.
    Abstract     Related articles   

  126. PARK S, Fudhaili A, Oh SS, Lee KW, et al
    Cytotoxic effects of kazinol A derived from Broussonetia papyrifera on human bladder cancer cells, T24 and T24R2.
    Phytomedicine. 2016;23:1462-1468.
    Abstract     Related articles   

  127. CHENG HP, Liu Q, Li Y, Li XD, et al
    The inhibitory effect of PDIA6 downregulation on bladder cancer cell proliferation and invasion.
    Oncol Res. 2016.
    Abstract     Related articles   

  128. DOGAN HS, Bozaci AC, Ozdemir B, Tonyali S, et al
    Ureteroneocystostomy in primary vesicoureteral reflux: critical retrospective analysis of factors affecting the postoperative urinary tract infection rates.
    Int Braz J Urol. 2014.
    Abstract     Related articles   

  129. CESARIO JM, Brito RB, Malta CS, Silva CS, et al
    A simple method to induce hypoxia-induced vascular endothelial growth factor-A (VEGF-A) expression in T24 human bladder cancer cells.
    In Vitro Cell Dev Biol Anim. 2016.
    Abstract     Related articles   

  130. ZERMANN DH, Vahlensieck W, Hoffmann W
    [Erratum to: Social medical/public health assessment of bladder cancer after curative and adjuvant therapy].
    Urologe A. 2016.
    Abstract     Related articles   

  131. KRAL M, Michalek J, Skarda J, Tichy T, et al
    High-grade urothelial bladder cancer in children: A case report and critical analysis of the literature.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016.
    Abstract     Related articles   

  132. ANDREU Z, Oshiro RO, Redruello A, Lopez-Martin S, et al
    Extracellular vesicles as a source for non-invasive biomarkers in bladder cancer progression.
    Eur J Pharm Sci. 2016 Oct 14. pii: S0928-0987(16)30431.
    Abstract     Related articles   

  133. MEEKS JJ, Carneiro BA, Pai SG, Oberlin DT, et al
    Genomic characterization of high-risk non-muscle invasive bladder cancer.
    Oncotarget. 2016 Oct 14. doi: 10.18632/oncotarget.12661.
    Abstract     Related articles   

  134. PEREIRA PM, Silva S, Bispo M, da Rocha Zuzarte M, et al
    Preclinical study on mitochondria-targeted photodynamic therapy using a galactodendritic chlorin for bladder cancer.
    Bioconjug Chem. 2016.
    Abstract     Related articles   

  135. ZHAO M, Yu S, Zhang M
    Differential expression of multidrug resistancerelated proteins in adriamycinresistant (pumc91/ADM) and parental (pumc91) human bladder cancer cell lines.
    Mol Med Rep. 2016 Oct 5. doi: 10.3892/mmr.2016.5806.
    Abstract     Related articles   

  136. KAMIYA N, Suzuki H, Suyama T, Kobayashi M, et al
    Clinical outcomes of second transurethral resection in non-muscle invasive high-grade bladder cancer: a retrospective, multi-institutional, collaborative study.
    Int J Clin Oncol. 2016.
    Abstract     Related articles   

  137. ZHI Y, Pan J, Shen W, He P, et al
    Ginkgolide B Inhibits Human Bladder Cancer Cell Migration and Invasion Through MicroRNA-223-3p.
    Cell Physiol Biochem. 2016;39:1787-1794.
    Abstract     Related articles   

  138. MORALES-BARRERA R, Suarez C, de Castro AM, Racca F, et al
    Targeting fibroblast growth factor receptors and immune checkpoint inhibitors for the treatment of advanced bladder cancer: New direction and New Hope.
    Cancer Treat Rev. 2016;50:208-216.
    Abstract     Related articles   

  139. ROSENBLATT R, Johansson M, Alamdari F, Sidiki A, et al
    Sentinel node detection in muscle-invasive urothelial bladder cancer is feasible after neoadjuvant chemotherapy in all pT stages, a prospective multicenter report.
    World J Urol. 2016.
    Abstract     Related articles   

  140. CHEN M, Rothman N, Ye Y, Gu J, et al
    Pathway analysis of bladder cancer genome-wide association study identifies novel pathways involved in bladder cancer development.
    Genes Cancer. 2016;7.
    Abstract     Related articles   

  141. TAKAOKA EI, Miyazaki J, Ishikawa H, Kawai K, et al
    Long-term single-institute experience with trimodal bladder-preserving therapy with proton beam therapy for muscle-invasive bladder cancer.
    Jpn J Clin Oncol. 2016.
    Abstract     Related articles   

  142. HEIDEGGER I, Tulchiner G, Schafer G, Horninger W, et al
    Long term disease free survival with multimodal therapy in small cell bladder cancer.
    Eur J Med Res. 2016;21:40.
    Abstract     Related articles   

  143. DURAN I, Hagen C, Arranz JA, Apellaniz-Ruiz M, et al
    SNPs associated with activity and toxicity of cabazitaxel in patients with advanced urothelial cell carcinoma.
    Pharmacogenomics. 2016;17:463-71.
    Abstract     Related articles   

  144. BERNARDES FILHO F, de Melo AS, Pires AR, Lupi O, et al
    Cutaneous invasion from sarcomatoid urothelial carcinoma: clinical and dermatopathologic features.
    An Bras Dermatol. 2016;91:73-9.
    Abstract     Related articles   

  145. BAZRAFSHANI MR, Nowshadi PA, Shirian S, Daneshbod Y, et al
    Deletion/duplication mutation screening of TP53 gene in patients with transitional cell carcinoma of urinary bladder using multiplex ligation-dependent probe amplification.
    Cancer Med. 2016;5:145-52.
    Abstract     Related articles   

  146. GEYNISMAN DM, Handorf E, Wong YN, Doyle J, et al
    Advanced small cell carcinoma of the bladder: clinical characteristics, treatment patterns and outcomes in 960 patients and comparison with urothelial carcinoma.
    Cancer Med. 2016;5:192-9.
    Abstract     Related articles   

  147. PARK S, Cho MS, Kim KH
    A case report of urothelial carcinoma with combined micropapillary and plasmacytoid morphology in the urinary bladder.
    Diagn Cytopathol. 2016;44:124-7.
    Abstract     Related articles   

  148. YOUNES I, Frachet V, Rinaudo M, Jellouli K, et al
    Cytotoxicity of chitosans with different acetylation degrees and molecular weights on bladder carcinoma cells.
    Int J Biol Macromol. 2016;84:200-7.
    Abstract     Related articles   

  149. DUAN W, Du L, Jiang X, Wang R, et al
    Identification of a serum circulating lncRNA panel for the diagnosis and recurrence prediction of bladder cancer.
    Oncotarget. 2016 Oct 25. doi: 10.18632/oncotarget.12880.
    Abstract     Related articles   

  150. HONG X, Li T, Ling F, Yang D, et al
    Impact of surgical margin status on the outcome of bladder cancer treated by radical cystectomy: a meta-analysis.
    Oncotarget. 2016 Oct 25. doi: 10.18632/oncotarget.12907.
    Abstract     Related articles   

  151. HONG Z, Wu J, Li Q, Zhang S, et al
    Meta-analysis reveals no significant association between ERCC6 polymorphisms and bladder cancer risk.
    Int J Biol Markers. 2016 Oct 22:0. doi: 10.5301/jbm.5000236.
    Abstract     Related articles   

  152. HAU AM, Leivo MZ, Gilder AS, Hu JJ, et al
    mTORC2 activation is regulated by the urokinase receptor (uPAR) in bladder cancer.
    Cell Signal. 2016;29:96-106.
    Abstract     Related articles   

  153. ZHUO C, Li X, Zhuang H, Tian S, et al
    Evaluating the efficacy and safety of intravesical chemotherapies for non-muscle invasive bladder cancer: a network meta-analysis.
    Oncotarget. 2016 Oct 24. doi: 10.18632/oncotarget.12856.
    Abstract     Related articles   

  154. SARGOS P, Baumann BC, Eapen LJ, Bahl A, et al
    Adjuvant radiotherapy for pathological high-risk muscle invasive bladder cancer: time to reconsider?
    Transl Androl Urol. 2016;5:702-710.
    Abstract     Related articles   

  155. KLAILE Y, Schlack K, Boegemann M, Steinestel J, et al
    Variant histology in bladder cancer: how it should change the management in non-muscle invasive and muscle invasive disease?
    Transl Androl Urol. 2016;5:692-701.
    Abstract     Related articles   

  156. SORIA F, Moschini M, Korn S, Shariat SF, et al
    How to optimally manage elderly bladder cancer patients?
    Transl Androl Urol. 2016;5:683-691.
    Abstract     Related articles   

  157. MARKS P, Soave A, Shariat SF, Fajkovic H, et al
    Female with bladder cancer: what and why is there a difference?
    Transl Androl Urol. 2016;5:668-682.
    Abstract     Related articles   

  158. SMOLENSKY D, Rathore K, Cekanova M
    Molecular targets in urothelial cancer: detection, treatment, and animal models of bladder cancer.
    Drug Des Devel Ther. 2016;10:3305-3322.
    Abstract     Related articles   

  159. EARL J, Rico D, Carrillo-de-Santa-Pau E, Rodriguez-Santiago B, et al
    Erratum to: The UBC-40 Urothelial Bladder Cancer cell line index: a genomic resource for functional studies.
    BMC Genomics. 2016;17:829.
    Abstract     Related articles   

  160. ZHANG Y, Nolan M, Yamada H, Watanabe M, et al
    Dynamin2 GTPase contributes to invadopodia formation in invasive bladder cancer cells.
    Biochem Biophys Res Commun. 2016 Oct 19. pii: S0006-291X(16)31741.
    Abstract     Related articles   

  161. ALFANO M, Nebuloni M, Allevi R, Zerbi P, et al
    Linearized texture of three-dimensional extracellular matrix is mandatory for bladder cancer cell invasion.
    Sci Rep. 2016;6:36128.
    Abstract     Related articles   

  162. WANG G, Cao R, Wang Y, Qian G, et al
    Simvastatin induces cell cycle arrest and inhibits proliferation of bladder cancer cells via PPARgamma signalling pathway.
    Sci Rep. 2016;6:35783.
    Abstract     Related articles   

  163. ARRUDA RP, Mariano MB, Pereira CF, Lima GC, et al
    Laparoscopic Cystoprostatectomy for Bladder Cancer in a Male patient combined with open ileal conduit urinary diversion.
    Int Braz J Urol. 2016 Oct 25. doi: 10.1590/S1677-5538.IBJU.2014.0632.
    Abstract     Related articles   

  164. QI D, Li J, Que B, Su J, et al
    Long non-coding RNA DBCCR1-003 regulate the expression of DBCCR1 via DNMT1 in bladder cancer.
    Cancer Cell Int. 2016;16:81.
    Abstract     Related articles   

  165. SINGH P, Black P
    Emerging role of checkpoint inhibition in localized bladder cancer.
    Urol Oncol. 2016 Oct 21. pii: S1078-1439(16)30272.
    Abstract     Related articles   

  166. ROSENKRANTZ AB, Friedman KP, Ponzo F, Raad RA, et al
    Prospective Pilot Study to Evaluate the Incremental Value of PET Information in Patients With Bladder Cancer Undergoing 18F-FDG Simultaneous PET/MRI.
    Clin Nucl Med. 2016.
    Abstract     Related articles   

  167. QIAN K, Wang G, Cao R, Liu T, et al
    Capsaicin Suppresses Cell Proliferation, Induces Cell Cycle Arrest and ROS Production in Bladder Cancer Cells through FOXO3a-Mediated Pathways.
    Molecules. 2016;21.
    Abstract     Related articles   

  168. STARKOV KE, Bunimovich-Mendrazitsky S
    Dynamical properties and tumor clearance conditions for a nine-dimensional model of bladder cancer immunotherapy.
    Math Biosci Eng. 2016;13:1059-1075.
    Abstract     Related articles   

  169. SADEE C, Kashdan E
    A model of thermotherapy treatment for bladder cancer.
    Math Biosci Eng. 2016;13:1169-1183.
    Abstract     Related articles   

  170. SKOWRON KB, Pitroda SP, Namm JP, Balogun O, et al
    Basal Tumor Cell Isolation and Patient-Derived Xenograft Engraftment Identify High-Risk Clinical Bladder Cancers.
    Sci Rep. 2016;6:35854.
    Abstract     Related articles   

  171. NOSSIER AI, Mohammed OS, Fakhr El-Deen RR, Zaghloul AS, et al
    Gelatin-modified gold nanoparticles for direct detection of urinary total gelatinase activity: Diagnostic value in bladder cancer.
    Talanta. 2016;161:511-519.
    Abstract     Related articles   

  172. FERREIRA-TEIXEIRA M, Paiva-Oliveira D, Parada B, Alves V, et al
    Natural killer cell-based adoptive immunotherapy eradicates and drives differentiation of chemoresistant bladder cancer stem-like cells.
    BMC Med. 2016;14:163.
    Abstract     Related articles   

  173. HUANG HH, Kuo SM, Wu YJ, Su JH, et al
    Improvement and enhancement of antibladder carcinoma cell effects of heteronemin by the nanosized hyaluronan aggregation.
    Int J Nanomedicine. 2016;11:1237-51.
    Abstract     Related articles   

  174. BACON N, Souza CH, Franz S
    Total cysto-prostatectomy: Technique description and results in 2 dogs.
    Can Vet J. 2016;57:141-6.
    Abstract     Related articles   

  175. SOKOLOV A, Paull EO, Stuart JM
    ONE-CLASS DETECTION OF CELL STATES IN TUMOR SUBTYPES.
    Pac Symp Biocomput. 2016;21:405-16.
    Abstract     Related articles   

  176. ZHANG Y, Wang X, Hoffman RM, Seki N, et al
    Real Time Metastatic Route Tracking of Orthotopic PC-3-GFP Human Prostate Cancer Using Intravital Imaging.
    J Cell Biochem. 2016;117:1027-32.
    Abstract     Related articles   

  177. PIETRUSINSKI M, Kepczynski, Jedrzejczyk A, Borkowska E, et al
    Detection of bladder cancer in urine sediments by a hypermethylation panel of selected tumor suppressor genes.
    Cancer Biomark. 2016.
    Abstract     Related articles   

  178. GARCIA J, Santome L, Anido U, Fernandez-Calvo O, et al
    Metastatic Bladder Cancer: Second-Line Treatment and Recommendations of the Genitourinary Tumor Division of the Galician Oncologic Society (SOG-GU).
    Curr Oncol Rep. 2016;18:72.
    Abstract     Related articles   

  179. SCARPA ES, Emanuelli M, Frati A, Pozzi V, et al
    Betacyanins enhance vitexin-2-O-xyloside mediated inhibition of proliferation of T24 bladder cancer cells.
    Food Funct. 2016.
    Abstract     Related articles   

  180. JIN X, Ma J, Liang X, Tang K, et al
    Pre-instillation of tumor microparticles enhances intravesical chemotherapy of nonmuscle-invasive bladder cancer through a lysosomal pathway.
    Biomaterials. 2016;113:93-104.
    Abstract     Related articles   

  181. DONG D, Jiang W, Lei J, Chen L, et al
    Ubiquitin-like protein FAT10 promotes bladder cancer progression by stabilizing survivin.
    Oncotarget. 2016 Oct 28. doi: 10.18632/oncotarget.12976.
    Abstract     Related articles   

  182. MANDAIR GS, Han AL, Keller ET, Morris MD, et al
    Raman microscopy of bladder cancer cells expressing green fluorescent protein.
    J Biomed Opt. 2016;21:115001.
    Abstract     Related articles   

  183. SUI W, Matulay JT, Onyeji IC, Theofanides MC, et al
    Contemporary treatment patterns and outcomes of sarcomatoid bladder cancer.
    World J Urol. 2016.
    Abstract     Related articles   

  184. MORALES A
    Administration of Mycobacterium phlei cell wall-nucleic acid complex in the immediate postoperative period for the treatment of non-muscle-invasive bladder cancer.
    Can Urol Assoc J. 2016;10.
    Abstract     Related articles   

  185. ZLOTTA AR
    What's new in bladder cancer research?
    Can Urol Assoc J. 2016;10.
    Abstract     Related articles   

  186. MATULEWICZ RS, Frainey BT, Oberlin DT, Meeks JJ, et al
    High-Risk of Adverse Pathologic Features in Patients With Clinical T1 High-Grade Bladder Cancer Undergoing Radical Cystectomy.
    J Natl Compr Canc Netw. 2016;14:1403-1411.
    Abstract     Related articles   

  187. LEE S, Jang J, Jeon H, Lee J, et al
    Latent Kaposi's sarcoma-associated herpesvirus infection in bladder cancer cells promotes drug resistance by reducing reactive oxygen species.
    J Microbiol. 2016;54:782-788.
    Abstract     Related articles   

  188. KU JH, Kim WJ, Lerner SP, Chun F, et al
    Diagnostic and Prognostic Markers in Bladder Cancer.
    Dis Markers. 2016;2016:2425091.
    Abstract     Related articles   

  189. KIM B, Kim G, Song B, Lee C, et al
    HER2 Protein Overexpression and Gene Amplification in Plasmacytoid Urothelial Carcinoma of the Urinary Bladder.
    Dis Markers. 2016;2016:8463731.
    Abstract     Related articles   

  190. CONCONI D, Sala E, Bovo G, Strada G, et al
    Using Copy Number Alterations to Identify New Therapeutic Targets for Bladder Carcinoma.
    Int J Mol Sci. 2016;17:271.
    Abstract     Related articles   

  191. KHAN M, O'Kane D, Du Plessis J, Hoag N, et al
    Primary malignant melanoma of the urinary bladder and ureter.
    Can J Urol. 2016;23:8171-5.
    Abstract     Related articles   

  192. PATNE SC, Katiyar R, Chaudhary D, Trivedi S, et al
    Dysuria and fever in a young woman diagnosed as having inflammatory myofibroblastic tumour of the urinary bladder.
    BMJ Case Rep. 2016;2016.
    Abstract     Related articles   

  193. CUI Y, Chen H, Liu L, Chen J, et al
    Comparing the Efficiency and Safety of Bipolar and Monopolar Transurethral Resection for Non-Muscle Invasive Bladder Tumors: A Systematic Review and Meta-Analysis.
    J Laparoendosc Adv Surg Tech A. 2016;26:196-202.
    Abstract     Related articles   

  194. PINKERNEIL M, Hoffmann MJ, Deenen R, Kohrer K, et al
    Inhibition of Class I Histone Deacetylases 1 and 2 Promotes Urothelial Carcinoma Cell Death by Various Mechanisms.
    Mol Cancer Ther. 2016;15:299-312.
    Abstract     Related articles   

  195. CHANG HY, Chang TC, Huang WY, Lee CT, et al
    RON Nuclear Translocation under Hypoxia Potentiates Chemoresistance to DNA Double-Strand Break-Inducing Anticancer Drugs.
    Mol Cancer Ther. 2016;15:276-86.
    Abstract     Related articles   

  196. ERDMANN E, Harding S, Lam H, Perez A, et al
    10-Year Observational Follow-Up of PROactive: a randomized cardiovascular outcomes trial evaluating pioglitazone in type 2 diabetes.
    Diabetes Obes Metab. 2015 Nov 23. doi: 10.1111/dom.12608.
    Abstract     Related articles   

  197. WANG B, Li X, Ming S, Ma X, et al
    Combined Extraperitoneal and Transperitoneal Laparoscopic Extended Partial Cystectomy for the Treatment of Urachal Carcinoma.
    J Endourol. 2016;30:280-5.
    Abstract     Related articles   

  198. LI X, Gao Y, Zhou H, Xu W, et al
    The relationship between functional promoter -94 ins/del ATTG polymorphism in NF-kappa B1 gene and the risk of urinary cancer.
    Cancer Biomark. 2016;16:11-7.
    Abstract     Related articles   

  199. DI TRAPANI E, Sanchez-Salas R, Gandaglia G, Rocchini L, et al
    A nomogram predicting the cancer-specific mortality in patients eligible for radical cystectomy evaluating clinical data and neoadjuvant cisplatinum-based chemotherapy.
    World J Urol. 2016;34:207-13.
    Abstract     Related articles   

  200. SORIA F, Milla P, Fiorito C, Pisano F, et al
    Efficacy and safety of a new device for intravesical thermochemotherapy in non-grade 3 BCG recurrent NMIBC: a phase I-II study.
    World J Urol. 2016;34:189-95.
    Abstract     Related articles   

  201. WANG H, Ke C, Ma X, Zhao Q, et al
    MicroRNA-92 promotes invasion and chemoresistance by targeting GSK3beta and activating Wnt signaling in bladder cancer cells.
    Tumour Biol. 2016.
    Abstract     Related articles   

  202. HU H, Chen Y, Cheng S, Li G, et al
    Dysregulated expression of homebox gene HOXA13 is correlated with the poor prognosis in bladder cancer.
    Wien Klin Wochenschr. 2016.
    Abstract     Related articles   

  203. QUIRT JS, Siemens DR, Zaza K, Mackillop WJ, et al
    Patterns of Referral to Radiation Oncology among Patients with Bladder Cancer: a Population-based Study.
    Clin Oncol (R Coll Radiol). 2016 Nov 6. pii: S0936-6555(16)30319.
    Abstract     Related articles   

  204. TSUJIMURA N, Yamada NO, Kuranaga Y, Kumazaki M, et al
    A Novel Role of Dickkopf-Related Protein 3 in Macropinocytosis in Human Bladder Cancer T24 Cells.
    Int J Mol Sci. 2016;17.
    Abstract     Related articles   

  205. RIETHDORF S, Pantel K
    Liquid biopsies for surveillance and monitoring treatment response of bladder cancer.
    Ann Transl Med. 2016;4:379.
    Abstract     Related articles   

  206. TANIGUCHI Y, Nishikawa H, Karashima T, Yoshinaga Y, et al
    Frequency of reactive arthritis, uveitis, and conjunctivitis in Japanese patients with bladder cancer following intravesical BCG therapy: A 20-year, two-centre retrospective study.
    Joint Bone Spine. 2016 Nov 4. pii: S1297-319X(16)30169.
    Abstract     Related articles   

  207. SIDAWAY P
    Bladder cancer: Autologous NK cells active against high-risk cancer.
    Nat Rev Urol. 2016 Nov 8. doi: 10.1038/nrurol.2016.
    Abstract     Related articles   

  208. TAGLIABUE L, Russo G, Lucignani G
    18F-FDG PET/CT in Bladder Cancer.
    Clin Nucl Med. 2016;41:e522-e524.
    Abstract     Related articles   

  209. GUI-ZHONG L, Li-Bo M
    Bladder cancer in individuals with spinal cord injuries: a meta-analysis.
    Spinal Cord. 2016 Nov 8. doi: 10.1038/sc.2016.
    Abstract     Related articles   

  210. WEI L, Chintala S, Ciamporcero E, Ramakrishnan S, et al
    Genomic profiling is predictive of response to cisplatin treatment but not to PI3K inhibition in bladder cancer patient-derived xenografts.
    Oncotarget. 2016 Nov 3. doi: 10.18632/oncotarget.13062.
    Abstract     Related articles   

  211. KANG W, Cui Z, Chen Q, Zhang D, et al
    Narrow band imaging-assisted transurethral resection reduces the recurrence risk of non-muscle invasive bladder cancer: A systematic review and meta-analysis.
    Oncotarget. 2016 Nov 3. doi: 10.18632/oncotarget.13054.
    Abstract     Related articles   

  212. OHTAKE S, Kawahara T, Kasahara R, Ito H, et al
    Pretreatment Neutrophil-to-Lymphocyte Ratio Can Predict the Prognosis in Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy.
    Biomed Res Int. 2016;2016:9846823.
    Abstract     Related articles   

  213. HANSEN E, Larsson H, Norgaard M, Thind P, et al
    The Danish Bladder Cancer Database.
    Clin Epidemiol. 2016;8:439-443.
    Abstract     Related articles   

  214. DI MASO M, Bosetti C, Taborelli M, Montella M, et al
    Dietary water intake and bladder cancer risk: An Italian case-control study.
    Cancer Epidemiol. 2016;45:151-156.
    Abstract     Related articles   

  215. CHEN YJ, Wang HF, Liang M, Zou RC, et al
    Upregulation of miR-3658 in bladder cancer and tumor progression.
    Genet Mol Res. 2016;15.
    Abstract     Related articles   

  216. RADY EA, Hassanein WA, Elhaddad TA
    The power Lomax distribution with an application to bladder cancer data.
    Springerplus. 2016;5:1838.
    Abstract     Related articles   

  217. ZHOU TC, Sankin AI, Porcelli SA, Perlin DS, et al
    A review of the PD-1/PD-L1 checkpoint in bladder cancer: From mediator of immune escape to target for treatment.
    Urol Oncol. 2016 Nov 2. pii: S1078-1439(16)30309.
    Abstract     Related articles   

  218. BOULANGER M, Tual S, Lemarchand C, Guizard AV, et al
    Agricultural exposure and risk of bladder cancer in the AGRIculture and CANcer cohort.
    Int Arch Occup Environ Health. 2016.
    Abstract     Related articles   

  219. ZHOU M, Wang S, Hu L, Liu F, et al
    miR-199a-5p suppresses human bladder cancer cell metastasis by targeting CCR7.
    BMC Urol. 2016;16:64.
    Abstract     Related articles   

  220. VERRILLI AM, Hohenhaus AE, Le Roux AB, Donovan TA, et al
    What Is Your Diagnosis?: Primary pulmonary neoplasia.
    J Am Vet Med Assoc. 2016;248:493-6.
    Abstract     Related articles   

  221. PAPADIMITRIOU JC, Randhawa P, Rinaldo CH, Drachenberg CB, et al
    BK Polyomavirus Infection and Renourinary Tumorigenesis.
    Am J Transplant. 2016;16:398-406.
    Abstract     Related articles   

  222. SAMARATUNGA H, Delahunt B, Egevad L, Adamson M, et al
    Pleomorphic giant cell carcinoma of the urinary bladder: an extreme form of tumour de-differentiation.
    Histopathology. 2016;68:533-40.
    Abstract     Related articles   

  223. HUANG K, Chen G, Li Y, Liu JK, et al
    [Expression of PAK1 in bladder cancer and its influence on invasion of bladder cancer cells].
    Zhonghua Yi Xue Za Zhi. 2016;96:3227-3231.
    Abstract     Related articles   

  224. PANDYA S, Sutaria J
    1809: FOOTDROP AS A HARBINGER OF METASTATIC BLADDER CANCER.
    Crit Care Med. 2016;44.
    Abstract     Related articles   

  225. OCHOA AE, Choi W, Su X, Siefker-Radtke A, et al
    Specific micro-RNA expression patterns distinguish the basal and luminal subtypes of muscle-invasive bladder cancer.
    Oncotarget. 2016 Nov 10. doi: 10.18632/oncotarget.13284.
    Abstract     Related articles   

  226. STEINBERG GD
    Bladder cancer: Assessing the conundrum of microscopic haematuria.
    Nat Rev Urol. 2016 Nov 15. doi: 10.1038/nrurol.2016.
    Abstract     Related articles   

  227. ITAM S, Elhage O, Khan MS
    Large leiomyoma of the bladder masquerading as an enlarged prostate gland.
    BMJ Case Rep. 2016;2016.
    Abstract     Related articles   

  228. KIM KH, Kabir E, Jahan SA
    The use of personal hair dye and its implications for human health.
    Environ Int. 2016;89-90:222-7.
    Abstract     Related articles   

  229. BUISSON Y
    [Congres de la Societe de pathologie exotique : parasitoses, mycoses et cancer 18 novembre 2015, Institut Pasteur, Paris].
    Bull Soc Pathol Exot. 2016;109:46-50.
    Abstract     Related articles   

  230. YOSHIKAWA H, Nolan MW, Lewis DW, Larue SM, et al
    RETROSPECTIVE EVALUATION OF INTERFRACTION URETERAL MOVEMENT IN DOGS UNDERGOING RADIATION THERAPY TO ELUCIDATE APPROPRIATE SETUP MARGINS.
    Vet Radiol Ultrasound. 2016;57:170-9.
    Abstract     Related articles   

  231. CECI C, Tentori L, Atzori MG, Lacal PM, et al
    Ellagic Acid Inhibits Bladder Cancer Invasiveness and In Vivo Tumor Growth.
    Nutrients. 2016;8.
    Abstract     Related articles   

  232. ZHANG Z, Zhang G, Kong C
    Targeted inhibition of Polo-like kinase 1 by a novel small-molecule inhibitor induces mitotic catastrophe and apoptosis in human bladder cancer cells.
    J Cell Mol Med. 2016 Nov 23. doi: 10.1111/jcmm.13018.
    Abstract     Related articles   

  233. DONG L, Lin F, Wu W, Huang W, et al
    Transcriptional cofactor Mask2 is required for YAP-induced cell growth and migration in bladder cancer cell.
    J Cancer. 2016;7:2132-2138.
    Abstract     Related articles   

  234. FUNT SA, Rosenberg JE
    Systemic, perioperative management of muscle-invasive bladder cancer and future horizons.
    Nat Rev Clin Oncol. 2016 Nov 22. doi: 10.1038/nrclinonc.2016.
    Abstract     Related articles   

  235. VAN HOOREN L, Sandin LC, Moskalev I, Ellmark P, et al
    Local checkpoint inhibition of CTLA-4 as a monotherapy or in combination with anti-PD1 prevents the growth of murine bladder cancer.
    Eur J Immunol. 2016 Nov 22. doi: 10.1002/eji.201646583.
    Abstract     Related articles   

  236. HOSSEINI SA, Zanganeh S, Akbarnejad E, Salehi F, et al
    Microfluidic device for label-free quantitation and distinction of bladder cancer cells from the blood cells using micro machined silicon based electrical approach; suitable in urinalysis assays.
    J Pharm Biomed Anal. 2016;134:36-42.
    Abstract     Related articles   


  237. Erratum to: Baumann BC, Bosch WR, Bahl A, et al. Development and validation of consensus contouring guidelines for adjuvant radiation therapy for bladder cancer after radical cystectomy. Int J Radiat Oncol Biol Phys 2016;96:78-86.
    Int J Radiat Oncol Biol Phys. 2016;96:1129.
    Abstract     Related articles   

  238. URQUIDI V, Netherton M, Gomes-Giacoia E, Serie DJ, et al
    A microRNA biomarker panel for the non-invasive detection of bladder cancer.
    Oncotarget. 2016 Nov 16. doi: 10.18632/oncotarget.13382.
    Abstract     Related articles   

  239. WANG H, Niu L, Jiang S, Zhai J, et al
    Comprehensive analysis of aberrantly expressed profiles of lncRNAs and miRNAs with associated ceRNA network in muscle-invasive bladder cancer.
    Oncotarget. 2016 Nov 15. doi: 10.18632/oncotarget.13363.
    Abstract     Related articles   

  240. CHEN X, Gu P, Xie R, Han J, et al
    Heterogeneous nuclear ribonucleoprotein K is associated with poor prognosis and regulates proliferation and apoptosis in bladder cancer.
    J Cell Mol Med. 2016 Nov 10. doi: 10.1111/jcmm.12999.
    Abstract     Related articles   

  241. TOKAS T, Avgeris M, Alamanis C, Scorilas A, et al
    Downregulated KLK13 expression in bladder cancer highlights tumor aggressiveness and unfavorable patients' prognosis.
    J Cancer Res Clin Oncol. 2016.
    Abstract     Related articles   

  242. YU C, Hequn C, Longfei L, Long W, et al
    GSTM1 and GSTT1 polymorphisms are associated with increased bladder cancer risk: Evidence from updated meta-analysis.
    Oncotarget. 2016 Nov 29. doi: 10.18632/oncotarget.13702.
    Abstract     Related articles   

  243. SORIA F, Moschini M, Abufaraj M, Wirth GJ, et al
    Preoperative anemia is associated with disease recurrence and progression in patients with non-muscle-invasive bladder cancer.
    Urol Oncol. 2016 Nov 28. pii: S1078-1439(16)30362.
    Abstract     Related articles   

  244. WANG X, Liang Z, Xu X, Li J, et al
    miR-148a-3p represses proliferation and EMT by establishing regulatory circuits between ERBB3/AKT2/c-myc and DNMT1 in bladder cancer.
    Cell Death Dis. 2016;7:e2503.
    Abstract     Related articles   

  245. NAN YH, Wang J, Wang Y, Sun PH, et al
    MiR-4295 promotes cell growth in bladder cancer by targeting BTG1.
    Am J Transl Res. 2016;8:4892-4901.
    Abstract     Related articles   

  246. HUANG B, Zhai W, Hu G, Huang C, et al
    MicroRNA-206 acts as a tumor suppressor in bladder cancer via targeting YRDC.
    Am J Transl Res. 2016;8:4705-4715.
    Abstract     Related articles   

  247. NOUHAUD FX, Rigaud J, Saint F, Colombel M, et al
    Final results of the phase III URO-BCG 4 multicenter study: efficacy and tolerance of one-third dose BCG maintenance in nonmuscle invasive bladder cancer.
    Anticancer Drugs. 2016.
    Abstract     Related articles   

  248. HOU L, Hong X, Dai M, Chen P, et al
    Association of smoking status with prognosis in bladder cancer: A meta-analysis.
    Oncotarget. 2016 Nov 25. doi: 10.18632/oncotarget.13606.
    Abstract     Related articles   

  249. DING C, Wu K, Wang W, Guan Z, et al
    Synthesis of a cell penetrating peptide modified superparamagnetic iron oxide and MRI detection of bladder cancer.
    Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13578.
    Abstract     Related articles   

  250. MENDEZ WM JR, Eftim S, Cohen J, Warren I, et al
    Relationships between arsenic concentrations in drinking water and lung and bladder cancer incidence in U.S. counties.
    J Expo Sci Environ Epidemiol. 2016 Nov 30. doi: 10.1038/jes.2016.
    Abstract     Related articles   

  251. LAZARO M, Gallardo E, Domenech M, Pinto A, et al
    SEOM Clinical Guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2016).
    Clin Transl Oncol. 2016.
    Abstract     Related articles   

  252. VU VAN D, Heberling U, Wirth MP, Fuessel S, et al
    Validation of the diagnostic utility of urinary midkine for the detection of bladder cancer.
    Oncol Lett. 2016;12:3143-3152.
    Abstract     Related articles   

  253. ARAFAT W, Darwish A, Naoum GE, Sameh W, et al
    Comparison between standard and reduced volume radiotherapy in bladder preservation trimodality protocol for muscle-invasive bladder cancer patients.
    Ecancermedicalscience. 2016;10:682.
    Abstract     Related articles   

  254. SRIVASTAVA AK, Singh PK, Singh D, Dalela D, et al
    Clinical utility of urinary soluble Fas in screening for bladder cancer.
    Asia Pac J Clin Oncol. 2016;12:e215-21.
    Abstract     Related articles   

  255. YAMASHITA H, Amponsa VO, Warrick JI, Zheng Z, et al
    On a FOX hunt: functions of FOX transcriptional regulators in bladder cancer.
    Nat Rev Urol. 2016 Nov 29. doi: 10.1038/nrurol.2016.
    Abstract     Related articles   

  256. KANIGEL WINNER KR, Costello JC
    A SPATIOTEMPORAL MODEL TO SIMULATE CHEMOTHERAPY REGIMENS FOR HETEROGENEOUS BLADDER CANCER METASTASES TO THE LUNG.
    Pac Symp Biocomput. 2016;22:611-622.
    Abstract     Related articles   

  257. KOJIMA T, Kawai K, Miyazaki J, Nishiyama H, et al
    Biomarkers for precision medicine in bladder cancer.
    Int J Clin Oncol. 2016.
    Abstract     Related articles   

  258. ZHANG N, Jiang G, Liu X, Na R, et al
    Prediction of Bacillus Calmette-Guerin Response in Patients with Bladder Cancer after Transurethral Resection of Bladder Tumor by Using Genetic Variation Based on Genomic Studies.
    Biomed Res Int. 2016;2016:9859021.
    Abstract     Related articles   

  259. KATO T, Yasuda K, Iida H, Watanabe A, et al
    Trousseau's syndrome caused by bladder cancer producing granulocyte colony-stimulating factor and parathyroid hormone-related protein: A case report.
    Oncol Lett. 2016;12:4214-4218.
    Abstract     Related articles   

  260. EGLOFF SA, Du L, Loomans HA, Starchenko A, et al
    Shed urinary ALCAM is an independent prognostic biomarker of three-year overall survival after cystectomy in patients with bladder cancer.
    Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13546.
    Abstract     Related articles   

  261. XIANG W, Wu X, Huang C, Wang M, et al
    PTTG1 regulated by miR-146-3p promotes bladder cancer migration, invasion, metastasis and growth.
    Oncotarget. 2016 Nov 22. doi: 10.18632/oncotarget.13507.
    Abstract     Related articles   

  262. ZHANG X, Yang X, Yang C, Li P, et al
    Targeting protein kinase CK2 suppresses bladder cancer cell survival via the glucose metabolic pathway.
    Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13571.
    Abstract     Related articles   

  263. HAHN NM
    New treatments for bladder cancer.
    Clin Adv Hematol Oncol. 2016;14:884-887.
    Abstract     Related articles   

  264. WARRICK JI, Walter V, Yamashita H, Chung E, et al
    FOXA1, GATA3 and PPAR Cooperate to Drive Luminal Subtype in Bladder Cancer: A Molecular Analysis of Established Human Cell Lines.
    Sci Rep. 2016;6:38531.
    Abstract     Related articles   

  265. SELINSKI S, Burger H, Blaszkewicz M, Otto T, et al
    Occupational risk factors for relapse-free survival in bladder cancer patients.
    J Toxicol Environ Health A. 2016;79.
    Abstract     Related articles   

  266. YU GQ, Dou ZL, Jia ZH
    5bromo3(3hydroxyprop1ynyl)2Hpyran2one induces apoptosis in T24 human bladder cancer cells through mitochondria-dependent signaling pathways.
    Mol Med Rep. 2016 Dec 6. doi: 10.3892/mmr.2016.5991.
    Abstract     Related articles   

  267. AKAZA H
    Bladder cancer: Advancing NMIBC treatment beyond current BCG formulations.
    Nat Rev Urol. 2016 Dec 6. doi: 10.1038/nrurol.2016.
    Abstract     Related articles   

  268. CHIU HF, Chen BK, Yang CY
    Parity, Age at First Birth, and Risk of Death from Bladder Cancer: A Population-Based Cohort Study in Taiwan.
    Int J Environ Res Public Health. 2016;13.
    Abstract     Related articles   

  269. KOPSIAFTIS S, Hegde P, Taylor JA 3rd, Claffey KP, et al
    AMPKalpha Is Suppressed in Bladder Cancer through Macrophage-Mediated Mechanisms.
    Transl Oncol. 2016;9:606-616.
    Abstract     Related articles   

  270. LI HT, Duymich CE, Weisenberger DJ, Liang G, et al
    Genetic and Epigenetic Alterations in Bladder Cancer.
    Int Neurourol J. 2016;20.
    Abstract     Related articles   

  271. MARTINI A, Villari D, Nicita G
    Editorial comment to: Ileal versus sigmoid neobladder as bladder substitute after radical cystectomy for bladder cancer: A meta-analysis.
    Int J Surg. 2016 Nov 29. pii: S1743-9191(16)31148.
    Abstract     Related articles   

  272. TERRERI S, Durso M, Colonna V, Romanelli A, et al
    New Cross-Talk Layer between Ultraconserved Non-Coding RNAs, MicroRNAs and Polycomb Protein YY1 in Bladder Cancer.
    Genes (Basel). 2016;7.
    Abstract     Related articles   

  273. HONG Z, Li H, Li L, Wang W, et al
    Different expression patterns of histone H3K27 demethylases in renal cell carcinoma and bladder cancer.
    Cancer Biomark. 2016.
    Abstract     Related articles   

  274. KOIE T, Ohyama C, Yamamoto H, Imai A, et al
    The feasibility and effectiveness of robot-assisted radical cystectomy after neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer.
    Jpn J Clin Oncol. 2016.
    Abstract     Related articles   

  275. SAHU D, Gupta S, Hau AM, Nakashima K, et al
    Argininosuccinate Synthetase 1 Loss in Invasive Bladder Cancer Regulates Survival through General Control Nonderepressible 2 Kinase-Mediated Eukaryotic Initiation Factor 2alpha Activity and Is Targetable by Pegylated Arginine Deiminase.
    Am J Pathol. 2016 Dec 9. pii: S0002-9440(16)30407.
    Abstract     Related articles   

  276. YANG R, Liu M, Liang H, Guo S, et al
    miR-138-5p contributes to cell proliferation and invasion by targeting Survivin in bladder cancer cells.
    Mol Cancer. 2016;15:82.
    Abstract     Related articles   

  277. ANGHEL RM, Gales LN, Trifanescu OG
    Outcome of urinary bladder cancer after combined therapies.
    J Med Life. 2016;9:95-100.
    Abstract     Related articles   

  278. ZHOU Y, Chan CF, Kwong DW, Law GL, et al
    alphavbeta3-Isoform specific erbium complexes highly specific for bladder cancer imaging and photodynamic therapy.
    Chem Commun (Camb). 2016.
    Abstract     Related articles   

  279. HEIDEGGER I, Oberaigner W, Horninger W, Pichler R, et al
    High incidence of clinically significant concomitant prostate cancer in patients undergoing radical cystectomy for bladder cancer: A 10-year single-center experience.
    Urol Oncol. 2016 Dec 9. pii: S1078-1439(16)30370.
    Abstract     Related articles   

  280. HUGEN CM, Duddalwar V, Daneshmand S
    Preoperative Imaging for Clinical Staging Prior to Radical Cystectomy.
    Curr Urol Rep. 2016;17:62.
    Abstract     Related articles   

  281. WINNENBURG R, Shah NH
    Generalized enrichment analysis improves the detection of adverse drug events from the biomedical literature.
    BMC Bioinformatics. 2016;17:250.
    Abstract     Related articles   

  282. LIM S, Koh MJ, Jeong HJ, Cho NH, et al
    Fibroblast Growth Factor Receptor 1 Overexpression Is Associated with Poor Survival in Patients with Resected Muscle Invasive Urothelial Carcinoma.
    Yonsei Med J. 2016;57:831-9.
    Abstract     Related articles   

  283. ARTCIBASOVA AV, Korzinkin MB, Sorokin MI, Shegay PV, et al
    MiRImpact, a new bioinformatic method using complete microRNA expression profiles to assess their overall influence on the activity of intracellular molecular pathways.
    Cell Cycle. 2016;15:689-98.
    Abstract     Related articles   

  284. LIU S, Zou L, Mao S, Zhang L, et al
    The safety and efficacy of bladder cryoablation in a beagle model by using a novel balloon cryoprobe.
    Cryobiology. 2016;72:157-60.
    Abstract     Related articles   

  285. UESHIMA H, Myint KZ, Otake H
    Detection of large perforating artery by ultrasound prescan before obturator nerve block.
    J Clin Anesth. 2016;29:14.
    Abstract     Related articles   

  286. ROMAN-JIMENEZ G, Crevoisier RD, Leseur J, Devillers A, et al
    Detection of bladder metabolic artifacts in (18)F-FDG PET imaging.
    Comput Biol Med. 2016;71:77-85.
    Abstract     Related articles   

  287. NECCHI A, Lo Vullo S, Mariani L, Raggi D, et al
    An open-label, single-arm, phase 2 study of the Aurora kinase A inhibitor alisertib in patients with advanced urothelial cancer.
    Invest New Drugs. 2016;34:236-42.
    Abstract     Related articles   

  288. KUBOTA H, Takahashi S, Monzawa S, Yuasa N, et al
    Pictorial review of orthotopic neobladder reconstruction: indication, normal postsurgical anatomy, and complications.
    Abdom Radiol (NY). 2016;41:356-67.
    Abstract     Related articles   

  289. MORGAN MS, Antonelli JA, Lotan Y, Shakir N, et al
    Use of an Electronic Medical Record to Assess Patient-Reported Morbidity Following Ureteroscopy.
    J Endourol. 2016;30 Suppl 1:S46-51.
    Abstract     Related articles   

  290. NADEEM H, Jayakrishnan TT, Rajeev R, Johnston FM, et al
    Cost Differential of Chemotherapy for Solid Tumors.
    J Oncol Pract. 2016;12:e299-307.
    Abstract     Related articles   

  291. PANER GP, Lopez-Beltran A, Sirohi D, Amin MB, et al
    Updates in the Pathologic Diagnosis and Classification of Epithelial Neoplasms of Urachal Origin.
    Adv Anat Pathol. 2016;23:71-83.
    Abstract     Related articles   

  292. ZENG X, Xu Z, Gu J, Huang H, et al
    Induction of miR-137 by Isorhapontigenin (ISO) Directly Targets Sp1 Protein Translation and Mediates Its Anticancer Activity Both In Vitro and In Vivo.
    Mol Cancer Ther. 2016;15:512-22.
    Abstract     Related articles   

  293. BALL MW, Nathan R, Gerayli F
    Long-Term Response After Surgery and Adjuvant Chemoradiation for T4 Mucinous Adenocarcinoma of the Bladder: A Case Report and Review of the Literature.
    Clin Genitourin Cancer. 2016;14:e225-7.
    Abstract     Related articles   

  294. RETZ M, Gschwend JE, Schmid SC
    [Update 2016 - Immunotherapy for urothelial carcinoma].
    Urologe A. 2016;55:246-52.
    Abstract     Related articles   

  295. BIENTINESI R, Ragonese M, Pinto F, Bassi PF, et al
    Paraneoplastic Dermatomyositis Associated With Panurothelial Transitional Cell Carcinoma: A Case Report and Literature Review.
    Clin Genitourin Cancer. 2016;14:e199-201.
    Abstract     Related articles   

  296. VALLONTHAIEL AG, Kaur K, Jain D, Singh G, et al
    Ewing Sarcoma of Urinary Bladder Showing EWSR1 Rearrangement on FISH Analysis and Unique Response to Chemotherapy.
    Clin Genitourin Cancer. 2016;14:e183-6.
    Abstract     Related articles   

  297. DE SANTIS M, Wiechno PJ, Bellmunt J, Lucas C, et al
    Vinflunine-gemcitabine versus vinflunine-carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: results of an international randomized phase II trial (JASINT1).
    Ann Oncol. 2016;27:449-54.
    Abstract     Related articles   

  298. GOLDBERG H, Baniel J, Mano R, Rotlevy G, et al
    Orthotopic neobladder vs. ileal conduit urinary diversion: A long-term quality-of-life comparison.
    Urol Oncol. 2016;34:121.
    Abstract     Related articles   

  299. CAPOGROSSO P, Capitanio U, Ventimiglia E, Boeri L, et al
    Detrusor Muscle in TUR-Derived Bladder Tumor Specimens: Can We Actually Improve the Surgical Quality?
    J Endourol. 2016;30:400-5.
    Abstract     Related articles   

  300. MAEBAYASHI T, Ishibashi N, Aizawa T, Sakaguchi M, et al
    Radiotherapy for Muscle-invasive Bladder Cancer in Very Elderly Patients.
    Anticancer Res. 2016;36:4763-9.
    Abstract     Related articles   

  301. CHANG WS, Liao CH, Tsai CW, Hu PS, et al
    Association of Enhancer of Zeste 2 (EZH2) Genotypes with Bladder Cancer Risk in Taiwan.
    Anticancer Res. 2016;36:4509-14.
    Abstract     Related articles   

  302. SAKAGUCHI M, Maebayashi T, Aizawa T, Ishibashi N, et al
    Clinical Results for Bladder Cancer Treated by Radiotherapy Without Concurrent Standard Chemotherapy.
    Anticancer Res. 2016;36:5519-5525.
    Abstract     Related articles   

  303. KRIEGMAIR MC, Balk M, Wirtz R, Steidler A, et al
    Expression of the p53 Inhibitors MDM2 and MDM4 as Outcome Predictor in Muscle-invasive Bladder Cancer.
    Anticancer Res. 2016;36:5205-5213.
    Abstract     Related articles   

  304. FERNANDEZ MI, Williams SB, Willis DL, Slack RS, et al
    Clinical Risk Stratification in Patients with Surgically Resectable Micropapillary Bladder Cancer.
    BJU Int. 2016 Oct 18. doi: 10.1111/bju.13689.
    Abstract     Related articles   

  305. ALJABERY F, Shabo I, Olson H, Gimm O, et al
    Radio-guided sentinel lymph node detection and lymph node mapping in invasive urinary bladder cancer-a prospective clinical study.
    BJU Int. 2016 Oct 31. doi: 10.1111/bju.13700.
    Abstract     Related articles   

  306. PARDINI B, Viberti C, Naccarati A, Allione A, et al
    Increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of bladder cancer.
    Br J Cancer. 2016 Dec 13. doi: 10.1038/bjc.2016.
    Abstract     Related articles   

  307. OJERHOLM E, Smith A, Hwang WT, Baumann BC, et al
    Neutrophil-to-lymphocyte ratio as a bladder cancer biomarker: Assessing prognostic and predictive value in SWOG 8710.
    Cancer. 2016 Oct 27. doi: 10.1002/cncr.30422.
    Abstract     Related articles   

  308. INMAN BA, Longo TA, Ramalingam S, Harrison MR, et al
    Atezolizumab: a PD-L1 blocking antibody for bladder cancer.
    Clin Cancer Res. 2016 Nov 30. pii: clincanres.1417.2016.
    Abstract     Related articles   

  309. CHOPRA S, Abreu AL, Gill IS
    Robotic urinary diversion: the range of options.
    Curr Opin Urol. 2016;26:107-13.
    Abstract     Related articles   

  310. LIEM EI, de Reijke TM
    Can we improve transurethral resection of the bladder tumour for nonmuscle invasive bladder cancer?
    Curr Opin Urol. 2016.
    Abstract     Related articles   

  311. GOOSSENS ME, Zeegers MP, van Poppel H, Joniau S, et al
    Phase III randomised chemoprevention study with selenium on the recurrence of non-invasive urothelial carcinoma. The SELEnium and BLAdder cancer Trial.
    Eur J Cancer. 2016;69:9-18.
    Abstract     Related articles   

  312. HERMANS TJ, Fransen van de Putte EE, Horenblas S, Meijer RP, et al
    Pathological downstaging and survival after induction chemotherapy and radical cystectomy for clinically node-positive bladder cancer-Results of a nationwide population-based study.
    Eur J Cancer. 2016;69:1-8.
    Abstract     Related articles   

  313. VAN DER HEIJDEN AG, Mengual L
    Reply to letter commenting on: A five-gene expression signature to predict progression in T1G3 bladder cancer.
    Eur J Cancer. 2016 Oct 30. pii: S0959-8049(16)32449.
    Abstract     Related articles   

  314. ORSOLA A, Mullane SA, Bellmunt J
    Letter to the Editor, Re: van der Heijden AG, Mengual L, Lozano JJ, Ingelmo-Torres M, Ribal MJ, Fernandez PL, Oosterwijk E, Schalken JA, Alcaraz A, Witjes JA. A five-gene expression signature to predict progression in T1G3 bladder cancer. Eur J Cancer
    Eur J Cancer. 2016 Oct 30. pii: S0959-8049(16)32448.
    Abstract     Related articles   

  315. LUO HL, Chen YT, Cheng YT, Chiang PH, et al
    Re: Thomas Seisen, Benoit Peyronnet, Jose Luis Dominguez-Escrig, et al. Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Can
    Eur Urol. 2016 Sep 26. pii: S0302-2838(16)30663.
    Abstract     Related articles   

  316. SEISEN T, Babjuk M, Roupret M
    Reply to Hao Lun Luo, Yen Ta Chen, Yuan Tso Cheng, and Po Hui Chiang's Letter to the Editor re: Re: Thomas Seisen, Benoit Peyronnet, Jose Luis Dominguez-Escrig, et al. Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for
    Eur Urol. 2016 Sep 22. pii: S0302-2838(16)30662.
    Abstract     Related articles   

  317. SATKUNASIVAM R, Santomauro M, Chopra S, Plotner E, et al
    Robotic Intracorporeal Orthotopic Neobladder: Urodynamic Outcomes, Urinary Function, and Health-related Quality of Life.
    Eur Urol. 2016;69:247-53.
    Abstract     Related articles   

  318. KAMAT AM, Briggman J, Urbauer DL, Svatek R, et al
    Cytokine Panel for Response to Intravesical Therapy (CyPRIT): Nomogram of Changes in Urinary Cytokine Levels Predicts Patient Response to Bacillus Calmette-Guerin.
    Eur Urol. 2016;69:197-200.
    Abstract     Related articles   

  319. SYLVESTER RJ, Oosterlinck W, Holmang S, Sydes MR, et al
    Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa-pT1 Urothelial Carci
    Eur Urol. 2016;69:231-44.
    Abstract     Related articles   

  320. NECCHI A, Giardiello D, Mariani L
    Methodological Considerations for Early-phase Development of Immune Checkpoint Inhibitors in Urothelial Bladder Cancer.
    Eur Urol. 2016 Oct 6. pii: S0302-2838(16)30684.
    Abstract     Related articles   

  321. LIEDBERG F, Jancke G, Sorenby A, Kannisto P, et al
    Should we Refrain from Performing Oophorectomy in Conjunction with Radical Cystectomy for Bladder Cancer?
    Eur Urol. 2016 Oct 19. pii: S0302-2838(16)30713.
    Abstract     Related articles   

  322. PICKARD R
    Is Robot-assisted Cystectomy Better than Open?--Nearing an Answer after a Decade of Use.
    Eur Urol. 2016;69:622-3.
    Abstract     Related articles   

  323. HAMILTON-REEVES JM, Bechtel MD, Hand LK, Schleper A, et al
    Effects of Immunonutrition for Cystectomy on Immune Response and Infection Rates: A Pilot Randomized Controlled Clinical Trial.
    Eur Urol. 2016;69:389-92.
    Abstract     Related articles   

  324. KAMEYAMA K, Horie K, Mizutani K, Kato T, et al
    Enzalutamide inhibits proliferation of gemcitabine-resistant bladder cancer cells with increased androgen receptor expression.
    Int J Oncol. 2016 Nov 24. doi: 10.3892/ijo.2016.3781.
    Abstract     Related articles   

  325. WANG JP, Jiao Y, Wang CY, Xu ZB, et al
    Rb knockdown accelerates bladder cancer progression through E2F3 activation.
    Int J Oncol. 2016 Dec 6. doi: 10.3892/ijo.2016.3791.
    Abstract     Related articles   

  326. CHEN L, Wang G, Luo Y, Wang Y, et al
    Downregulation of LAPTM5 suppresses cell proliferation and viability inducing cell cycle arrest at G0/G1 phase of bladder cancer cells.
    Int J Oncol. 2016 Dec 5. doi: 10.3892/ijo.2016.3788.
    Abstract     Related articles   

  327. HERMANS TJ, van de Putte EE, Horenblas S, van Rhijn BW, et al
    Extended pelvic lymph node dissection at radical cystectomy for bladder cancer improves survival: Results of a nationwide population-based study.
    Int J Urol. 2016 Oct 4. doi: 10.1111/iju.13227.
    Abstract     Related articles   

  328. REIS LO
    Editorial Comment to Orthotopic mouse model of renal pelvic cancer using a human bladder cancer cell line.
    Int J Urol. 2016;23:963.
    Abstract     Related articles   

  329. VIDAL A, Arnold N, Vartolomei MD, Kiss B, et al
    Oncological and functional outcomes of postoperative total parenteral nutrition after radical cystectomy in bladder cancer patients: A single-center randomized trial.
    Int J Urol. 2016 Oct 21. doi: 10.1111/iju.13228.
    Abstract     Related articles   

  330. BESIROGLU H
    Re: Role of routine computed tomography scan in the oncological follow up of patients treated by radical cystectomy for bladder cancer.
    Int J Urol. 2016 Dec 1. doi: 10.1111/iju.13269.
    Abstract     Related articles   

  331. MAURICE MJ, Kim SP, Abouassaly R
    Socioeconomic status is associated with urinary diversion utilization after radical cystectomy for bladder cancer.
    Int Urol Nephrol. 2016.
    Abstract     Related articles   

  332. LI HM, Azhati B, Rexiati M, Wang WG, et al
    Impact of smoking status and cumulative smoking exposure on tumor recurrence of non-muscle-invasive bladder cancer.
    Int Urol Nephrol. 2016.
    Abstract     Related articles   

  333. MAY M, Protzel C, Vetterlein MW, Gierth M, et al
    Is there evidence for a close connection between side of intravesical tumor location and ipsilateral lymphatic spread in lymph node-positive bladder cancer patients at radical cystectomy? Results of the PROMETRICS 2011 database.
    Int Urol Nephrol. 2016.
    Abstract     Related articles   

  334. ATALA A
    Re: Regulation of UHRF1 by Dual-Strand Tumor-Suppressor MicroRNA-145 (miR-145-5p and miR-145-3p): Inhibition of Bladder Cancer Cell Aggressiveness.
    J Urol. 2016;196:1314.
    Abstract     Related articles   

  335. CHANG SS
    Re: Investigation of Multisequence Magnetic Resonance Imaging for Detection of Recurrent Tumor after Transurethral Resection for Bladder Cancer.
    J Urol. 2016;196:1045.
    Abstract     Related articles   

  336. CHANG SS
    Re: Quality of Life in Patients with Non-Muscle-Invasive Bladder Cancer: One-Year Results of a Multicentre Prospective Cohort Study.
    J Urol. 2016;196:1045-6.
    Abstract     Related articles   

  337. CHANG SS
    Re: Gene Expression Test for the Non-Invasive Diagnosis of Bladder Cancer: A Prospective, Blinded, International and Multicenter Validation Study.
    J Urol. 2016;196:1044-6.
    Abstract     Related articles   

  338. CHOU R, Selph S, Buckley DI, Fu R, et al
    Comparative effectiveness of fluorescent versus white light cystoscopy for initial diagnosis or surveillance of bladder cancer on clinical outcomes: Systematic review and meta-analysis.
    J Urol. 2016 Oct 22. pii: S0022-5347(16)31585-3. doi: 10.1016/j.juro.2016.
    Abstract     Related articles   

  339. CHANG SS
    Re: Long-Term Follow-up of TaG1 Non-Muscle-Invasive Bladder Cancer.
    J Urol. 2017;197:52-54.
    Abstract     Related articles   

  340. WANG DS
    Re: Long-Term Changes in Renal Function Outcomes following Radical Cystectomy and Urinary Diversion.
    J Urol. 2016;195:1511.
    Abstract     Related articles   

  341. MOREY AF
    Re: Outcomes of the Endoscopic Treatment of Bladder Neck Contractures in the Orthotopic Neobladder.
    J Urol. 2016;195:1508-9.
    Abstract     Related articles   

  342. CHANG SS
    Re: Oncologic Outcomes following Robot-Assisted Radical Cystectomy with Minimum 5-Year Follow-up: The Roswell Park Cancer Institute Experience.
    J Urol. 2016;195:1381-2.
    Abstract     Related articles   

  343. VENKATRAMANI V, Parekh DJ
    Editorial Comment.
    J Urol. 2016;195:1375.
    Abstract     Related articles   

  344. KRISHNAN N, Liu X, Lavieri MS, Hu M, et al
    A Model to Optimize Followup Care and Reduce Hospital Readmissions after Radical Cystectomy.
    J Urol. 2016;195:1362-7.
    Abstract     Related articles   

  345. ZHANG H, Ye YL, Li MX, Ye SB, et al
    CXCL2/MIF-CXCR2 signaling promotes the recruitment of myeloid-derived suppressor cells and is correlated with prognosis in bladder cancer.
    Oncogene. 2016 Oct 10. doi: 10.1038/onc.2016.
    Abstract     Related articles   

  346. COCCIA A, Mosca L, Puca R, Mangino G, et al
    Extra-virgin olive oil phenols block cell cycle progression and modulate chemotherapeutic toxicity in bladder cancer cells.
    Oncol Rep. 2016 Oct 5. doi: 10.3892/or.2016.5150.
    Abstract     Related articles   

  347. VARINOT J, Furudoi A, Roupret M, Comperat E, et al
    [Update on molecular classifications and new histological classification of bladder cancer].
    Prog Urol. 2016 Sep 20. pii: S1166-7087(16)30419.
    Abstract     Related articles   

  348. IRANI J
    [Intravesical instillations in non-muscle-invasive bladder cancer (NMIBC). Prospects for thermochemotherapy].
    Prog Urol. 2016 Oct 3. pii: S1166-7087(16)30564.
    Abstract     Related articles   

  349. DABI Y, Rouscoff Y, Delongchamps NB, Sibony M, et al
    [Negative prognostic impact of female gender on oncological outcomes following radical cystectomy].
    Prog Urol. 2016;26:83-8.
    Abstract     Related articles   

  350. ROUPRET M, Neuzillet Y, Masson-Lecomte A, Colin P, et al
    [CCAFU french national guidelines 2016-2018 on bladder cancer].
    Prog Urol. 2016;27 Suppl 1:S67-S91.
    Abstract     Related articles   

  351. D'ELIA C, Comploj E, Cerruto MA, Trenti E, et al
    90-Day Mortality after Radical Cystectomy for Bladder Cancer: Prognostic Factors in a Multicenter Case Series.
    Urol Int. 2016.
    Abstract     Related articles   

  352. SHIVAPPA N, Hebert JR, Rosato V, Rossi M, et al
    Dietary Inflammatory Index and Risk of Bladder Cancer in a Large Italian Case-Control Study.
    Urology. 2016 Sep 29. pii: S0090-4295(16)30637.
    Abstract     Related articles   

  353. ANANTHARAMAN A, Friedlander T, Lu D, Krupa R, et al
    Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients.
    BMC Cancer. 2016;16:744.
    Abstract     Related articles   

  354. BENHAMOU S, Bonastre J, Groussard K, Radvanyi F, et al
    A prospective multicenter study on bladder cancer: the COBLAnCE cohort.
    BMC Cancer. 2016;16:837.
    Abstract     Related articles   

  355. KONG C, Zhan B, Piao C, Zhang Z, et al
    Overexpression of UNC5B in bladder cancer cells inhibits proliferation and reduces the volume of transplantation tumors in nude mice.
    BMC Cancer. 2016;16:892.
    Abstract     Related articles   

  356. GARCIA MM, Gottschalk AR, Brajtbord J, Konety BR, et al
    Correction: Endoscopic Gold Fiducial Marker Placement into the Bladder Wall to Optimize Radiotherapy Targeting for Bladder-Preserving Management of Muscle-Invasive Bladder Cancer: Feasibility and Initial Outcomes.
    PLoS One. 2016;11:e0164558.
    Abstract     Related articles   

  357. XIE J, Codd C, Mo K, He Y, et al
    Differential Adverse Event Profiles Associated with BCG as a Preventive Tuberculosis Vaccine or Therapeutic Bladder Cancer Vaccine Identified by Comparative Ontology-Based VAERS and Literature Meta-Analysis.
    PLoS One. 2016;11:e0164792.
    Abstract     Related articles   

  358. KIM D, Choi Y, Ireland J, Foreman O, et al
    Development and Application of a Microfluidics-Based Panel in the Basal/Luminal Transcriptional Characterization of Archival Bladder Cancers.
    PLoS One. 2016;11:e0165856.
    Abstract     Related articles   

  359. LIMA L, Gaiteiro C, Peixoto A, Soares J, et al
    Reference Genes for Addressing Gene Expression of Bladder Cancer Cell Models under Hypoxia: A Step Towards Transcriptomic Studies.
    PLoS One. 2016;11:e0166120.
    Abstract     Related articles   

  360. LONG X, Zu X, Li Y, He W, et al
    Epidermal Growth Factor Receptor and Ki-67 as Predictive Biomarkers Identify Patients Who Will Be More Sensitive to Intravesical Instillations for the Prevention of Bladder Cancer Recurrence after Radical Nephroureterectomy.
    PLoS One. 2016;11:e0166884.
    Abstract     Related articles   

  361. DAI L, Ma C, Zhang Z, Zeng S, et al
    DAPK Promoter Methylation and Bladder Cancer Risk: A Systematic Review and Meta-Analysis.
    PLoS One. 2016;11:e0167228.
    Abstract     Related articles   

  362. KANEMOTO K, Fukuta K, Kawai N, Tozawa K, et al
    Genomic Landscape of Experimental Bladder Cancer in Rodents and Its Application to Human Bladder Cancer: Gene Amplification and Potential Overexpression of Cyp2a5/CYP2A6 Are Associated with the Invasive Phenotype.
    PLoS One. 2016;11:e0167374.
    Abstract     Related articles   

  363. WU Z, Wang C, Zhang Z, Liu W, et al
    High Expression of Derlin-1 Is Associated with the Malignancy of Bladder Cancer in a Chinese Han Population.
    PLoS One. 2016;11:e0168351.
    Abstract     Related articles   


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;